
外泌體是細胞分泌的奈米級囊泡(約 30–150 奈米),承載蛋白質、生長因子、核酸等訊息分子,是細胞之間傳遞訊號、協調修復與再生的關鍵媒介。相較於直接使用細胞,外泌體具備更佳的安全性、穩定性與可控性,是再生醫學與醫美領域備受矚目的前沿技術。
Exosomes are nano-scale vesicles (about 30–150 nm) secreted by cells, carrying proteins, growth factors and nucleic acids. They are key messengers that coordinate repair and regeneration between cells. Compared with using cells directly, exosomes offer greater safety, stability and control — a frontier technology in regenerative medicine and aesthetics.

積雪草(Centella Asiatica)自古即為知名的舒緩修復草本。ABio 以專利技術從積雪草萃取並純化植物外泌體,將其天然的舒緩與再生訊息因子,以奈米囊泡形式高效傳遞至肌膚細胞。Exo-CICA 是奧泌與肌泌兩大系列最主要的核心成分。
Centella Asiatica has long been prized for soothing and repair. Using patented methods, ABio extracts and purifies plant exosomes from Centella, delivering its natural soothing and regenerative signals to skin cells as nano-vesicles. Exo-CICA is the primary active across both the Cellexosome and Lumidor series.
快速穩定術後泛紅與敏感,加速肌膚修復。
Rapidly calms post-procedure redness and sensitivity.
活化纖維母細胞,促進膠原蛋白新生與彈性提升。
Activates fibroblasts to boost collagen and elasticity.
奈米級外泌體高效滲透,將有效成分送達目標細胞。
Nano-scale exosomes deliver actives deep to target cells.
降低引發皮膚免疫反應與副作用的可能性。
Lowers the chance of triggering immune response or side effects.
促進物質在細胞間移動,提高肌膚吸收效率。
Facilitates movement between cells, boosting skin absorption.
蛋白質、miRNA、脂質、mRNA 等生物活性物質,參與細胞間訊息傳遞。
Proteins, miRNA, lipids and mRNA that mediate cell-to-cell signaling.
4°C、25°C、45°C 下經 12 週實測,NTA 粒徑分佈依然穩定。
NTA particle distribution stays stable at 4/25/45°C over 12 weeks.
抗發炎、抗氧化、傷口癒合、神經保護等多重生物活性。
Anti-inflammatory, antioxidant, wound-healing and neuroprotective actions.
細胞與分子實驗顯示,Exo-CICA® 在再生、抗發炎、膠原重建與淨白四大面向皆有顯著表現。
Cell and molecular studies show Exo-CICA® performs across regeneration, anti-inflammation, collagen and brightening.
※ 數據來自 ABio 原廠外泌體研究資料,實際效果因人而異。
※ Data from ABio exosome research; individual results may vary.
ABio 以超過 20 年專研、62 項國際專利與 34 篇以上國際醫學期刊(SCI),建立從智慧農場、專利萃取到專利成分的完整科技鏈,奠定外泌體領導地位。
With 20+ years of research, 62 international patents and 34+ SCI papers, ABio built a complete chain — from Smart Farm to patented extraction to a patented ingredient.
Exo-CICA® 的原料,來自 ABio 以智慧農場技術培育的專屬新品種「HOIN 積雪草」。相較於一般產地的積雪草,HOIN 葉片明顯更大、更肥厚——葉片成長指標達其他地區品種的 2 倍,關鍵活性成分積雪草苷含量更高達 2–8 倍,讓活性成分的功效與含量同時「極大化」與「均一化」。
The raw material for Exo-CICA® comes from ABio's proprietary Smart-Farm strain, "HOIN" Centella. Its leaves are visibly larger and thicker than common regional varieties — with a leaf-growth index 2× that of other regions and asiaticoside content up to 2–8× higher — maximizing and standardizing both the potency and the content of the actives.
※ HOIN 為 ABio 專屬培育品種,已登錄韓國品種保護權(存續 2025–2045),由 ABiomaterials 與 AMOREPACIFIC 共同持有。
※ HOIN is ABio's proprietary strain, registered under Korean Plant Variety Protection (2025–2045), co-held by ABiomaterials and AMOREPACIFIC.
業界常見的萃取法多仰賴超高速離心(UC)、管柱層析(SEC)等物理分離方式,過程耗時且容易破壞外泌體膜結構。Exo-Traction® 採用專利雙水相分離技術(ATPs),全程零化學溶劑,讓外泌體完整保留雙層磷脂質膜與生物活性。
Common industry methods rely on physical separation such as ultracentrifugation (UC) or size-exclusion chromatography (SEC) — slow, and prone to damaging the exosome membrane. Exo-Traction® uses a patented aqueous two-phase separation process (ATPs), fully solvent-free, preserving the intact phospholipid bilayer and bioactivity.
| 比較項目 | Criteria | Exo-Traction® | Exo-Traction® | 業界常見萃取法 | Common industry methods |
|---|---|---|---|---|---|
| 萃取原理 | Method | 雙水相分離技術(ATPs) | Aqueous two-phase separation (ATPs) | 超高速離心/管柱層析等物理分離法 | Ultracentrifugation / SEC — physical separation |
| 化學溶劑 | Chemical solvents | 全程零溶劑 | Fully solvent-free | 部分方法需搭配化學試劑 | Some methods require chemical reagents |
| 外泌體完整性 | Exosome integrity | 零損傷,完整保留雙層磷脂質膜 | Zero-damage, intact phospholipid bilayer | 高速離心易破壞外泌體結構 | High-speed spin can damage the membrane |
| 純度 | Purity | 業界最高,提升 3.5 倍以上 | Industry-leading, 3.5×+ higher | 受限於方法,純度參差 | Purity varies by method |
| 產率 | Yield | 提升 3 倍以上 | 3×+ higher | 產率較低 | Lower yield |
| 處理速度 | Processing speed | 極快 | Very fast | 超高速離心法非常耗時 | Ultracentrifugation is very time-consuming |
| 量產穩定性 | Scalability | 規模化量產,大量且穩定 | Scalable, high-volume & consistent | 部分方法不易規模化 | Some methods are hard to scale |
※ 資料來源:ABio 原廠技術簡報(Exo-Traction® 專利萃取技術,ATPs 雙水相系統)。
※ Source: ABio technical materials on the Exo-Traction® patented extraction process (ATPs).
除了積雪草,ABio 已建立橫跨 29 種植物的外泌體萃取資料庫,涵蓋抗發炎、抗老化、抗落髮、亮白等多元功效,展現持續領先的研發實力。
Beyond Centella, ABio has built an exosome extraction library spanning 29 plant species — covering anti-inflammatory, anti-aging, anti-hairloss and brightening effects.
奧泌與肌泌兩大系列,將 Exo-CICA® 與外泌體科技轉化為專業療程與居家養護。
The Cellexosome and Lumidor series turn Exo-CICA® and exosome science into professional and home care.